STA
IBB icon

Summit Trail Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Summit Trail Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,760
Closed -$972K – 1469
2025
Q4 		$972K Hold
5,760
– – 0.02% 830
2025
Q3 		$832K Hold
5,760
– – 0.01% 920
2025
Q2 		$729K Buy
+5,760
New +$707K 0.01% 583
2024
Q4 		– Sell
-4,797
Closed -$698K – 550
2024
Q3 		$698K Hold
4,797
– – 0.02% 328
2024
Q2 		$658K Buy
+4,797
New +$640K 0.02% 315
2022
Q1 		– Sell
-16,240
Closed -$2.48M – 347
2021
Q4 		$2.48M Buy
+16,240
New +$2.51M 0.16% 80

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Summit Trail Advisors's IBB Position: Q1 2026 in Review

Summit Trail Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 5,760 shares — an estimated $972K sold.

Summit Trail Advisors first reported a position in IBB in Q4 2021 and held it in 6 quarters. The position peaked at $2.48M in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Summit Trail Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Summit Trail Advisors sold 5,760 iShares Biotechnology ETF shares in Q1 2026, an estimated $972K.
  • Summit Trail Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 6 quarters.
  • Summit Trail Advisors's iShares Biotechnology ETF position peaked at $2.48M in Q4 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.